Sigilon Therapeutics

2 followers

‌

Sigilon Therapeutics’ mission is to create immune-protected, engineered human cells that restore normal physiology in a wide range of diseases without generating fibrosis or immune rejection, liberating patients from challenges associated with serious chronic diseases.

Industries

Headquarters

Cambridge, United States

Employees

Links

Org chart

Rogerio Vivaldi

President & CEO

Rogerio Vivaldi

Collapse

Chief Technical Operations Officer

Philip Ashton-Rickardt

Chief Scientific Officer

VP & Head, Bioanalytical & CMC Analytical Development

Olivia G. Kelly

VP, Head, Islet Cell Therapy Research

VP & Head, Immune Mediated Diseases

VP, Finance & Controller

VP Of Finance & Controller

Co-founder

Senior Associate Engineer - Process Development

Jillian Higgins

Principle Associate Scientist

Corporate Director

Head Of Quality

Teams

Leadership Team

9 members

Administration and Executive Management

11 members

Scientific and Research Team

11 members

Advisors Team

5 members

Finance and Quality Team

4 members

Similar companies

Fortis Life Sciences

1 follower

Dragonfly Therapeutics

1 follower

Genesis Therapeutics

2 followers

Thermo Fisher Scientific

162 followers

Gilead Sciences

127 followers

Regeneron

92 followers

GRAIL

27 followers

Natera

13 followers

Ultragenyx Pharmaceutical

10 followers

UNITY Biotechnology

12 followers

NeoGenomics

8 followers

Explore companies